(Q38094662)

28 August 2017

title

Non-cognitive symptoms and related conditions in the Alzheimer's disease: a literature review (English)

1 reference

28 August 2017

0 references

Francesco Raudino

1

1 reference

28 August 2017

publication date

31 March 2013

1 reference

28 August 2017

published in

Neurological Sciences

1 reference

28 August 2017

volume

34

1 reference

28 August 2017

issue

8

1 reference

28 August 2017

page(s)

1275-1282

1 reference

https://scigraph.springernature.com/pub.10.1007/s10072-013-1424-7

28 August 2017

exact match

0 references

cites work

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Staging of Alzheimer's disease-related neurofibrillary changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Expression of tau immunoreactivity in the spinal motor neurons of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Spinal cord neurofibrillary pathology in Alzheimer disease and Guam Parkinsonism-dementia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Alzheimer disease: curly fibers and tangles in organs other than brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Increased risk for falling associated with subtle cognitive impairment: secondary analysis of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Non-neurological factors are implicated in impairments in gait and mobility among patients in a clinical dementia referral population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Different cognitive functions in relation to falls among older persons. Immediate memory as an independent risk factor for falls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Quantitative gait dysfunction and risk of cognitive decline and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Metabolic and hedonic drives in the neural control of appetite: who is the boss?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Olfaction in persons with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Functional representation of olfactory impairment in early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

The relationship between cerebral Alzheimer's disease pathology and odour identification in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Sensory network dysfunction, behavioral impairments, and their reversibility in an Alzheimer's β-amyloidosis mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Apolipoprotein E status is associated with odor identification deficits in nondemented older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Acute versus chronic pain treatment in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Pain and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

A systematic review of neuropsychiatric symptoms in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Course of neuropsychiatric symptoms during a 4-year follow up in the REAL-FR cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Depression and risk of developing dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Depressive symptoms predict longitudinal change in executive control but not memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Neuropathological correlates of late-life depression in older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Suicide and Alzheimer's pathology in the elderly: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Investigation of Alzheimer's disease-related pathology in community dwelling older subjects who committed suicide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

An evidence-based proposal for the classification of neuropsychiatric disturbance in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Early development of social deficits in APP and APP-PS1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Insight in Alzheimer's patients: results of a longitudinal study using three assessment methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Depression-dementia medius: between depression and the manifestation of dementia symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

The putative neurodegenerative links between depression and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Regional cerebral blood flow abnormalities associated with apathy and depression in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Cerebrospinal Fluid Alzheimer Markers in Depressed Elderly Subjects with and without Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Diabetes, Alzheimer's disease and apolipoprotein genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Beta-amyloid deposition in brains of subjects with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

The pathological interaction between diabetes and presymptomatic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

APL-1, the Alzheimer's Amyloid precursor protein in Caenorhabditis elegans, modulates multiple metabolic pathways throughout development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

The Parkinson's complex: parkinsonism is just the tip of the iceberg

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

Diet and oxidative stress: a novel synthesis of epidemiological data on Alzheimer's disease

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS10072-013-1424-7

21 January 2018

12 December 2020

Neurologic examination in an elderly population

1 reference

12 December 2020

Visuospatial ability in relation to fall risk and dementia

1 reference

12 December 2020

Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies

1 reference

12 December 2020

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

1 reference

12 December 2020

Olfactory deficits as a neurologic sign in dementia of the Alzheimer type

1 reference

12 December 2020

Clinical observations of impaired cranial nerve function in senile dementia

1 reference

12 December 2020

The impact of Alzheimer's disease on the functional connectivity between brain regions underlying pain perception

1 reference

12 December 2020

The epidemiology of psychosis in dementia

1 reference

12 December 2020

Electroneuromyographic findings in patients with Alzheimer's disease

1 reference

12 December 2020

10.1007/S10072-013-1424-7

Identifiers

DOI

1 reference

28 August 2017

1 reference